Zhenghuan Liu

Sichuan University

Papers

1

Total Citations

25

H-Index

1

About

Dr. Zhenghuan Liu is a leading urologic surgeon and researcher whose work centers on refining surgical techniques for kidney cancer treatment, with a particular focus on robot-assisted partial nephrectomy (RAPN). His major contribution lies in systematically evaluating the comparative effectiveness of retroperitoneal versus transperitoneal surgical approaches, offering evidence-based guidance to optimize patient outcomes. His most-cited paper, a 2021 meta-analysis comparing these two approaches in RAPN, has garnered 25 citations, underscoring its influence in shaping clinical decision-making. By synthesizing data from multiple databases—including PubMed, Web of Science, and Embase—Dr. Liu provides surgeons with clear insights into perioperative outcomes, helping to reduce complications and improve recovery times. His work is notable for its rigorous methodology and practical relevance, directly impacting how urologists approach nephron-sparing surgery. Through these contributions, Dr. Liu has established himself as a key voice in minimally invasive urologic oncology, advancing the field toward safer, more tailored surgical interventions for patients with renal tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Retroperitoneal or transperitoneal approach in robot‐assisted partial nephrectomy, which one is better?
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Sichuan University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago